Clinical Trials Logo

Filter by:
NCT ID: NCT01060709 Completed - Colonoscopy Clinical Trials

Transcutaneous Measurement of Carbon Dioxide Versus Current Sedation Practices in Sedated Patients

Start date: December 2009
Phase: N/A
Study type: Observational

Does transcutaneous carbon dioxide partial pressure (TcCO2) monitoring detect hypoventilation prior to current sedation monitoring practices in order to prevent hypoxemia in sedated patients undergoing colonoscopies?

NCT ID: NCT01060683 Completed - Clinical trials for Elective Hepatic Resection

Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry

Start date: January 2010
Phase:
Study type: Observational

The purpose of this study is to evaluate the accuracy of continuous SpHb measurement ( Rainbow DCI, Masimo, Irvine Ca, USA) compared to the current method of monitoring (blood sampling), both during phases of hemoconcentration and hemodilution.

NCT ID: NCT01060631 Completed - Clinical trials for Supratentorial Brain Tumor

Influence of Intracranial Lesions on Bispectral Index

Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess whether BIS values at return of consciousness are different in patients with or without brain tumors.

NCT ID: NCT01059773 Completed - Psoriasis Clinical Trials

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

TRANSIT
Start date: October 2009
Phase: Phase 4
Study type: Interventional

This purpose of this study is to assess the safety of ustekinumab in psoriasis patients who receive ustekinumab following an inadequate response to methotrexate therapy. The study will provide information for doctors on how to manage the transfer from methotrexate to the biologic agent ustekinumab. The study is designed to compare two methods of transferring patients from methotrexate to ustekinumab. The two methods being compared are discontinuation of methotrexate with immediate initiation of ustekinumab versus initiation of ustekinumab with overlap and gradual dose reduction of methotrexate over 4 weeks.

NCT ID: NCT01059630 Completed - Clinical trials for Non-Hodgkin's Lymphoma

A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

Start date: April 30, 2010
Phase: Phase 3
Study type: Interventional

This open-label, multicenter, randomized Phase III study will investigate the efficacy, safety, pharmacokinetics and pharmacoeconomics of obinutuzumab (RO5072759, GA101) combined with bendamustine followed by continued obinutuzumab treatment (maintenance monotherapy) compared with bendamustine alone treatment in participants with rituximab-refractory indolent Non-Hodgkin's lymphoma (iNHL). The end of study was defined to when safety follow-up for all patients had been completed (2 years' safety follow-up from last dose).

NCT ID: NCT01058772 Completed - Clinical trials for Gestational Diabetes

Gestational Diabetes: Induction Versus Expectant Management of Labour

GINEXMAL
Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether, in Gestational Diabetes Mellitus (GDM) pregnancies, induction of labour at 38-39 weeks of pregnancy is superior to expectant management in terms of maternal and neonatal outcomes.

NCT ID: NCT01058564 Completed - Clinical trials for Gastroesophageal Reflux Disease

A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter

Start date: May 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Evaluate a novel method of augmenting a weak Lower Esophageal Sphincter (LES).

NCT ID: NCT01058434 Completed - Clinical trials for Relapsed or Refractory Multiple Myeloma

Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation

Start date: May 2010
Phase: Phase 2
Study type: Interventional

This study will evaluate safety and efficacy of TKI258 in patients with relapsed or refractory multiple myeloma

NCT ID: NCT01058070 Completed - Clinical trials for Gastroesophageal Reflux Disease

An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

Start date: February 2007
Phase: N/A
Study type: Interventional

Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)

NCT ID: NCT01057810 Completed - Prostate Cancer Clinical Trials

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if patients with metastatic prostate cancer who have not received chemotherapy live longer when treated with ipilimumab than those treated with a placebo